Intrapallidal administration of 6-hydroxydopamine mimics in large part the electrophysiological and behavioral consequences of major dopamine depletion in the rat

Neuroscience

Volumn 236, Issue , 2013, Pages 289-297

  Abedi, P M ^a,b,c   Delaville, C ^a,b   De Deurwaerdere P ^a,b   Benjelloun, W ^c   Benazzouz, A ^a,b  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b CNRS   (France)

^c FACULTÉ DES SCIENCES   (Morocco)

Author keywords

Dopamine; Electrophysiology; Globus pallidus; Parkinson's disease; Substantia nigra pars reticulata; Subthalamic nucleus

Indexed keywords

DOPAMINE; OXIDOPAMINE; ADRENERGIC RECEPTOR STIMULATING AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BEHAVIOR; BRAIN ELECTROPHYSIOLOGY; BRAIN NERVE CELL; CATECHOLAMINE DEPLETION; CONTROLLED STUDY; CORPUS STRIATUM; FIRING RATE; GLOBUS PALLIDUS; IN VIVO STUDY; LOCOMOTION; MALE; MOTOR DYSFUNCTION; NONHUMAN; OPEN FIELD TEST; PARKINSON DISEASE; PAW; PRIORITY JOURNAL; RAT; RAT MODEL; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS; ANIMAL; DRUG EFFECT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; METABOLISM; MOTOR ACTIVITY; NERVE CELL; PATCH CLAMP; SPRAGUE DAWLEY RAT;

ADRENERGIC AGENTS; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOPAMINE; GLOBUS PALLIDUS; INJECTIONS, INTRAVENTRICULAR; MALE; MOTOR ACTIVITY; NEURONS; OXIDOPAMINE; PARKINSON DISEASE; PATCH-CLAMP TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84882932657     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.01.043     Document Type: Article

References (71)

1. Albin R.L., Young A.B., Penney J.B. The functional anatomy of basal ganglia disorders. Trends Neurosci 1989, 12:366-375.
2. Alexander G.E., Crutcher M.D. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci 1990, 13:266-271.
3. Anaya-Martinez V., Martinez-Marcos A., Martinez-Fong D., Aceves J., Erlij D. Substantia nigra compacta neurons that innervate the reticular thalamic nucleus in the rat also project to striatum or globus pallidus: Implications for abnormal motor behavior. Neuroscience 2006, 143:477-486.
4. Andén N.-E., Butcher S.G., Corrodi H., Fuxe K., Ungerstedt U. Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Eur J Pharmacol 1970, 11:303-314.
5. Baufreton J., Kirkham E., Atherton J.F., Menard A., Magill P.J., Bolam J.P., Bevan M.D. Sparse but selective and potent synaptic transmission from the globus pallidus to the subthalamic nucleus. J Neurophysiol 2009, 102:532-545.
6. Belujon P., Bezard E., Taupignon A., Bioulac B., Benazzouz A. Noradrenergic modulation of subthalamic nucleus activity: behavioral and electrophysiological evidence in intact and 6-hydroxydopamine-lesioned Rats. J Neurosci 2007, 27:9595-9606.
7. Benazzouz A., Breit S., Koudsie A., Pollak P., Krack P., Benabid A.-L. Intraoperative microrecordings of the subthalamic nucleus in Parkinson's disease. Mov Disord 2002, 17:S145-S149.
8. Benazzouz A., Gao D.M., Ni Z.G., Piallat B., Bouali-Benazzouz R., Benabid A.L. Effect of high-frequency stimulation of the subthalamic nucleus on the neuronal activities of the substantia nigra pars reticulata and ventrolateral nucleus of the thalamus in the rat. Neuroscience 2000, 99:289-295.
9. Benazzouz A., Gross C., Feger J., Boraud T., Bioulac B. Reversal of rigidity and improvement in motor performance by subthalamic high-frequency stimulation in MPTP-treated monkeys. Eur J Neurosci 1993, 5:382-389.
10. Bergman H., Wichmann T., Delong M.R. Reversal of experimental Parkinsonism by lesions of the subthalamic nucleus. Science 1990, 249:1436-1438.
11. Bergman H., Wichmann T., Karmon B., DeLong M.R. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism. J Neurophysiol 1994, 72:507-520.
12. Björklund A., Lindvall O. Dopamine-containing systems in the CNS. Handbook of chemical neuroanatomy: classical transmitters in the CNS, Part I 1984, vol. 2:55-122. Elsevier Press, Netherlands.
13. Bouali-Benazzouz R., Tai C.H., Chetrit J., Benazzouz A. Intrapallidal injection of 6-hydroxydopamine induced changes in dopamine innervation and neuronal activity of globus pallidus. Neuroscience 2009, 164:588-596.
14. Breit S., Bouali-Benazzouz R., Popa R.C., Gasser T., Benabid A.L., Benazzouz A. Effects of 6-hydroxydopamine-induced severe or partial lesion of the nigrostriatal pathway on the neuronal activity of pallido-subthalamic network in the rat. Exp Neurol 2007, 205:36-47.
15. Burbaud P., Gross C., Benazzouz A., Coussemacq M., Bioulac B. Reduction of apomorphine-induced rotational behaviour by subthalamic lesion in 6-OHDA lesioned rats is associated with a normalization of firing rate and discharge pattern of pars reticulata neurons. Exp Brain Res 1995, 105:48-58.
16. Chetrit J., Ballion B., Laquitaine S., Belujon P., Morin S., Taupignon A., Bioulac B., Gross C.E., Benazzouz A. Involvement of basal ganglia network in motor disabilities induced by typical antipsychotics. PLoS ONE 2009, 4:e6208.
17. Cooper A.J., Stanford I.M. Dopamine D2 receptor mediated presynaptic inhibition of striatopallidal GABAA IPSCs in vitro. Neuropharmacol 2001, 41:62-71.
18. Costall B., Naylor R.J., Olley J.E. Stereotypic and anticataleptic activities of amphetamine after intracerebral injections. Eur J Pharmacol 1972, 18:83-94.
19. De Deurwaerdère P., Stinus L., Spampinato U. Opposite change of in vivo dopamine release in the rat nucleus accumbens and striatum that follows electrical stimulation of dorsal raphe nucleus: role of 5-HT3 receptors. J Neurosci 1998, 18:6528-6538.
20. Delaville C., Chetrit J., Abdallah K., Morin S., Cardoit L., De Deurwaerdère P., Benazzouz A. Emerging dysfunctions consequent to combined monoaminergic depletions in parkinsonism. Neurobiol Dis 2012, 45:763-773.
21. Deniau JM, Mailly P, Maurice N, Charpier S (2007) The pars reticulata of the substantia nigra a window to basal ganglia output. In: Progr Brain Res, Vol. 160 (James M, Tepper EDA, Bolam JP, eds.), pp 151-172. Elsevier.
22. Ehringer H., Hornykiewicz O. Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system. Klin Wochenschr 1960, 38:1236-1239.
23. Fang X., Sugiyama K., Akamine S., Namba H. The stepping test and its learning process in different degrees of unilateral striatal lesions by 6-hydroxydopamine in rats. Neurosci Res 2006, 55:403-409.
24. Floran B., Aceves J., Sierra A., Martinez-Fong D. Activation of D1 dopamine receptors stimulates the release of GABA in the basal ganglia of the rat. Neurosci Lett 1990, 116:136-140.
25. Floran B., Floran L., Sierra A., Aceves J. D2 receptor-mediated inhibition of GABA release by endogenous dopamine in the rat globus pallidus. Neurosci Lett 1997, 237:1-4.
26. François C., Yelnik J., Faucheux B., Hirsch E.C., Agid Y. Le singe vert, un modèle pour l'étude du tremblement dans la maladie de Parkinson. Primatologie 1999, 2:357-379.
27. Fuchs H., Nagel J., Hauber W. Effects of physiological and pharmacological stimuli on dopamine release in the rat globus pallidus. Neurochem Int 2005, 47:474-481.
28. Galvan A., Floran B., Erlij D., Aceves J. Intrapallidal dopamine restores motor deficits induced by 6-hydroxydopamine in the rat. J Neural Transm 2001, 108:153-166.
29. Galvan A., Wichmann T. Pathophysiology of Parkinsonism. Clin Neurophysiol 2008, 119:1459-1474.
30. Hallworth N.E., Bevan M.D. Globus pallidus neurons dynamically regulate the activity pattern of subthalamic nucleus neurons through the frequency-dependent activation of postsynaptic GABAA and GABAB receptors. J Neurosci 2005, 25:6304-6315.
31. Hassani O.K., Mouroux M., Féger J. Increased subthalamic neuronal activity after nigral dopaminergic lesion independent of disinhibition via the globus pallidus. Neuroscience 1996, 72:105-115.
32. Hauber W., Lutz S. Dopamine D1 or D2 receptor blockade in the globus pallidus produces akinesia in the rat. Behav Brain Res 1999, 106:143-150.
33. Hauber W., Lutz S., Münkle M. The effects of globus pallidus lesions on dopamine-dependent motor behaviour in rats. Neuroscience 1998, 86:147-157.
34. Hernández A., Ibáñez-Sandoval O., Sierra A., Valdiosera R., Tapia D., Anaya V., Galarraga E., Bargas J., Aceves J. Control of the subthalamic innervation of the rat globus pallidus by D2/3 and D4 dopamine receptors. J Neurophysiol 2006, 96:2877-2888.
35. Hernández A., Sierra A., Valdiosera R., Florán B., Erlij D., Aceves J. Presynaptic D1 dopamine receptors facilitate glutamatergic neurotransmission in the rat globus pallidus. Neurosci Lett 2007, 425:188-191.
36. Hutchison W.D., Allan R.J., Opitz H., Levy R., Dostrovsky J.O., Lang A.E., Lozano A.M. Neurophysiological identification of the subthalamic nucleus in surgery for Parkinson's disease. Ann Neurol 1998, 44:622-628.
37. Jan C., François C., Tandé D., Yelnik J., Tremblay L., Agid Y., Hirsch E. Dopaminergic innervation of the pallidum in the normal state, in MPTP-treated monkeys and in parkinsonian patients. Eur J Neurosci 2000, 12:4525-4535.
38. Janssen M.L.F., Zwartjes D.G.M., Tan S.K.H., Vlamings R., Jahanshahi A., Heida T., Hoogland G., Steinbusch H.W.M., Visser-Vandewalle V., Temel Y. Mild dopaminergic lesions are accompanied by robust changes in subthalamic nucleus activity. Neurosci Lett 2012, 508:101-105.
39. Kaneoke Y., Vitek J.L. Burst and oscillation as disparate neuronal properties. J Neurosci Methods 1996, 68:211-223.
40. Kincaid A.E., Penney J.B., Young A.B., Newman S.W. The globus pallidus receives a projection from the parafascicular nucleus in the rat. Brain Res 1991, 553:18-26.
41. Kita H., Kita T. Role of striatum in the pause and burst generation in the globus pallidus of 6-OHDA treated rats. Front Syst Neurosci 2011, 5:42.
42. Kreiss D.S., Mastropietro C.W., Rawji S.S., Walters J.R. The response of subthalamic nucleus neurons to dopamine receptor stimulation in a rodent model of Parkinson's disease. J Neurosci 1997, 17:6807-6819.
43. Limousin P., Pollak P., Benazzouz A., Hoffmann D., Broussolle E., Perret J.E., Benabid A.-L. Bilateral subthalamic nucleus stimulation for severe Parkinson's disease. Mov Disord 1995, 10:672-674.
44. MacLeod N.K., Ryman A., Arbuthnott G.W. Electrophysiological properties of nigrothalamic neurons after 6-hydroxydopamine lesions in the rat. Neuroscience 1990, 38:447-456.
45. Meissner W., Leblois A., Hansel D., Bioulac B., Gross C.E., Benazzouz A., Boraud T. Subthalamic high frequency stimulation resets subthalamic firing and reduces abnormal oscillations. Brain 2005, 128:2372-2382.
46. Mouroux M., Hassani O.K., Féger J. Electrophysiological and Fos immunohistochemical evidence for the excitatory nature of the parafascicular projection to the globus pallidus. Neuroscience 1997, 81:387-397.
47. Murer M.G., Riquelme L.A., Tseng K.Y., Pazo J.H. Substantia nigra pars reticulata single unit activity in normal and 6-0HDA-lesioned rats: effects of intrastriatal apomorphine and subthalamic lesions. Synapse 1997, 27:278-293.
48. Ni Z., Bouali-Benazzouz R., Gao D., Benabid A.-L., Benazzouz A. Changes in the firing pattern of globus pallidus neurons after the degeneration of nigrostriatal pathway are mediated by the subthalamic nucleus in the rat. Eur J Neurosci 2000, 12:4338-4344.
49. Ni Z., Bouali-Benazzouz R., Gao D., Benabid A.-L., Benazzouz A. Intrasubthalamic injection of 6-hydroxydopamine induces changes in the firing rate and pattern of subthalamic nucleus neurons in the rat. Synapse 2001, 40:145-153.
50. Ni Z., Gao D., Bouali-Benazzouz R., Benabid A.-L., Benazzouz A. Effect of microiontophoretic application of dopamine on subthalamic nucleus neuronal activity in normal rats and in rats with unilateral lesion of the nigrostriatal pathway. Eur J Neurosci 2001, 14:373-381.
51. Nicola S.M., Surmeier D.J., Malenka R.C. Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens. Annu Rev Neurosci 2000, 23:185-215.
52. Olsson M., Nikkhah G., Bentlage C., Bjorklund A. Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test. J Neurosci 1995, 15:3863-3875.
53. Parent A., Hazrati L.-N. Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res Rev 1995, 20:91-127.
54. Parent A., Hazrati L.-N. Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidium in basal ganglia circuitry. Brain Res Rev 1995, 20:128-154.
55. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1998, Academic Press, New York.
56. Plenz D., Kital S.T. A basal ganglia pacemaker formed by the subthalamic nucleus and external globus pallidus. Nature 1999, 400:677-682.
57. Rajput A.H., Sitte H.H., Rajput A., Fenton M.E., Pifl C., Hornykiewicz O. Globus pallidus dopamine and Parkinson motor subtypes: clinical and brain biochemical correlation. Neurology 2008, 70:1403-1410.
58. Robledo P., Feger J. Acute monoaminergic depletion in the rat potentiates the excitatory effect of the subthalamic nucleus in the substantia nigra pars reticulata but not in the pallidal complex. J Neural Transm 1991, 86:115-126.
59. Rommelfanger K.S., Wichmann T. Extrastriatal dopaminergic circuits of the basal ganglia. Front Neuroanat 2010, 4:139.
60. Ruffieux A., Schultz W. Dopaminergic activation of reticulata neurones in the substantia nigra. Nature 1980, 285:240-241.
61. Sanderson P., Mavoungou R., Albe-Fessard D. Changes in substantia nigra pars reticulata activity following lesions of the substantia nigra pars compacta. Neurosci Lett 1986, 67:25-30.
62. Shin R.-M., Masuda M., Miura M., Sano H., Shirasawa T., Song W.-J., Kobayashi K., Aosaki T. Dopamine D4 receptor-induced postsynaptic inhibition of GABAergic currents in mouse globus pallidus neurons. J Neurosci 2003, 23:11662-11672.
63. Smith Y., Kieval J.Z. Anatomy of the dopamine system in the basal ganglia. Trends Neurosci 2000, 23(Suppl. 1):S28-S33.
64. Smith Y., Villalba R. Striatal and extrastriatal dopamine in the basal ganglia: an overview of its anatomical organization in normal and Parkinsonian brains. Mov Disord 2008, 23:S534-S547.
65. Soares J., Kliem M.A., Betarbet R., Greenamyre J.T., Yamamoto B., Wichmann T. Role of external pallidal segment in primate Parkinsonism: comparison of the effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism and lesions of the external pallidal segment. J Neurosci 2004, 24:6417-6426.
66. Tai C.-H., Boraud T., Bézard E., Bioulac B., Gross C., Benazzouz A. Electrophysiological and metabolic evidence that high-frequency stimulation of the subthalamic nucleus bridles neuronal activity in the subthalamic nucleus and the substantia nigra reticulata. FASEB J 2003, 17:1820-1830.
67. Tseng K.Y., Kasanetz F., Kargieman L., Pazo J.H., Murer M.G., Riquelme L.A. Subthalamic nucleus lesions reduce low frequency oscillatory firing of substantia nigra pars reticulata neurons in a rat model of Parkinson's disease. Brain Res 2001, 904:93-103.
68. Vila M., Périer C., Féger J., Yelnik J., Faucheux B., Ruberg M., Raisman-Vozari R., Agid Y., Hirsch E.C. Evolution of changes in neuronal activity in the subthalamic nucleus of rats with unilateral lesion of the substantia nigra assessed by metabolic and electrophysiological measurements. Eur J Neurosci 2000, 12:337-344.
69. Waszczak B.L., Walters J.R. A physiological role for dopamine as modulator of GABA effects in substantia nigra: supersensitivity in 6-hydroxydopamine-lesioned rats. Eur J Pharmacol 1984, 105:369-373.
70. Waszczak B.L., Walters J.R. Endogenous dopamine can modulate inhibition of substantia nigra pars reticulata neurons elicited by GABA iontophoresis or striatal stimulation. J Neurosci 1986, 6:120-126.
71. Weick B.G., Walters J.R. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses. Brain Res 1987, 405:234-246.